Skip to main content
. 2018 Jan 19;24(3):167–177. doi: 10.1111/cns.12786

Figure 4.

Figure 4

The prognostic performance of the six‐CpG signature in stratified cohorts by known epigenetic biomarkers; (A) risk classification of the six‐CpG signature and G‐CIMP status in a pooled survival analysis of all available patients; P‐values from meta‐analysis <0.01 for each pairwise comparison; (B) risk classification of the six‐CpG signature and G‐CIMP status in a pooled survival analysis of all available patients with combination of RT and TMZ; P‐values from meta‐analysis <0.01 for each pairwise comparison, except for the comparison of low‐risk and MGMT unmethylated tumors vs high‐risk and unmethylated ones (P = 0.540)